Statin/Icariin Formulations with Increased Solubility AgCenter scientists have developed a new encapsulation formulation to increase the solubility of statin and icariin compounds. The increase in solubility was tens of thousands fold for both compounds according to lab experiments. This can greatly increase the bioavailability, or absorption into the body, of statin- and icariin-related drugs. Both concepts have been formulated into powders with relatively high drug loads. All ingredients used in the process are natural. |
Natural Blood Vessel Growth-inhibiting Compound This invention is a novel combination of natural extracts that has the ability to strongly inhibit the development of blood vessels that feed cancer and other diseases related to blood vessel growth, such as psoriasis. The synergistic interaction of these materials increases efficacy, and the body can readily absorb the extracts through the skin. This material also has shown promise in vitro to overcome cells’ natural drug resistance and defenses. |
|
|
|
Natural Cell Signaling Pathway Inhibiting Extract A new natural plant extract has been discovered that inhibits cell signaling pathways to prevent certain cells from communicating and growing. By strongly inhibiting multiple cell signaling pathways, such as mTOR and P13K/Akt, this new material can eliminate very late-stage prostate cancers that have previously been difficult to treat. It also can block certain proteins and enzymes linked to diabetes, obesity and tissue inflammation. |
Natural Drug Solubilizing Extract This new group of compounds uses natural extracts to increase the solubility of drugs. Unlike other solubility-enhancing compounds, these will work on molecules of any size and will not slow down the speed at which drugs enter circulation and move throughout the body. This technology has been licensed. Please contact the AgCenter Office of Intellectual Property for information on partnering with our licensee. |
|
|